Tech Press Laos: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Press Laos.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 8, 2026

January 8, 2026

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

GlobeNewswire

January 8, 2026

Atsena Completes Dosing in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-linked Retinoschisis and Announces Plans for Initiation of Pivotal Part C Cohort

GlobeNewswire

January 8, 2026

ElevateBio Achieves Sixth Consecutive Year of Revenue Growth Driven by Expansion of its Genetic Medicine Technology and Manufacturing Business

GlobeNewswire

January 8, 2026

Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases

GlobeNewswire

January 8, 2026

ZenaTech Completes 20th Acquisition in Year One of Drone as a Service, Strengthening California Wildfire Management and Public Works Opportunities

GlobeNewswire

January 8, 2026

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11

GlobeNewswire

January 8, 2026

AGM Group Announces Strategic Memorandum of Understanding with Amber Premium in Building RWA Tokenization Initiatives

GlobeNewswire

January 8, 2026

SchoolAI Research Challenges Fears About AI in the Classroom with Evidence From 23,000 Teacher-Created Lessons

GlobeNewswire

January 8, 2026

Microchip Releases Custom Firmware For NVIDIA DGX Spark For Its MEC1723 Embedded Controllers

GlobeNewswire

January 8, 2026

Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights

GlobeNewswire

January 8, 2026

Indivior Provides Full-Year 2026 Financial Guidance and Business Update

GlobeNewswire

January 8, 2026

Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study

GlobeNewswire

January 8, 2026

AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)

GlobeNewswire

January 8, 2026

Enara Bio Enters 2026 with Dark Antigen Licensing to Boehringer Ingelheim, Appointment of Chief Medical Officer and Plans to Advance DARKFOX T-cell Engager into First-in-Human Studies

GlobeNewswire

January 8, 2026

Tisento Therapeutics Completes Enrollment in PRIZM, a Global Phase 2b Study of Zagociguat for the Treatment of MELAS

GlobeNewswire

January 8, 2026

AAVantgarde to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 8, 2026

Aronora Appoints Industry Leaders to Drive Next Phase of Growth

GlobeNewswire

January 8, 2026

Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference

GlobeNewswire

January 8, 2026

Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy

GlobeNewswire

January 8, 2026

GlycoEra Appoints Petra Duda, M.D., Ph.D., as Chief Medical Officer to Advance Precision Immune Degrader Pipeline

GlobeNewswire